SLU-PP-332
SLU-PP-332 is a novel PPAR-delta agonist designed to mimic the metabolic effects of exercise at the cellular level. It enhances mitochondrial function, promotes fat oxidation, and improves endurance. Often studied for its potential to increase energy efficiency and metabolic health, SLU-PP-332 is recognized as a cutting-edge performance compound.
Product Info
Molecular formula: N/A (experimental peptide)
Molecular weight: N/A
Purity: 99%+
Sequence: N/A
Reconstitution and Storage
Most standard lyophilised research vials use 2mL of bacteriostatic water for preparation. However, always check the product page or vial label for specific instructions.
For best handling, slowly add the bacteriostatic water along the inside wall of the vial. Avoid adding it directly onto the powder. This approach helps reduce unnecessary agitation and supports product integrity during laboratory use.
Next, gently swirl or roll the vial until the lyophilised powder fully dissolves. Avoid aggressive shaking. Excessive agitation may affect product stability.
After preparation, store the vial in a refrigerator between 2–8°C for best stability. Meanwhile, keep unprepared lyophilised vials in a cool, dry environment. Protect them from direct sunlight, moisture, and excessive heat.
Finally, follow the storage and handling instructions provided with each product. Proper handling helps maintain product purity, consistency, and reliability throughout laboratory applications.
SLU-PP-332 in Canada
Polar Peptides supplies SLU-PP-332 in Canada as a lyophilised powder in sealed 5mg research vials. You can order one vial or choose a 3-vial or 10-vial pack. The vial contains the compound as bulk powder. Therefore, laboratories can set their own working concentrations.
About the SLU-PP-332 Vial Format
This powder format leaves concentration entirely to the laboratory. That flexibility matters for tool compounds such as SLU-PP-332. Researchers typically screen synthetic agonists across a wide concentration range. They can then establish a suitable working level for their study.
SLU-PP-332 is a small synthetic molecule that targets the estrogen-related receptor family. Saint Louis University developed the compound, which explains the initials in its name. These receptors have no firmly established natural binding partner. Therefore, researchers can use designed agonists to study their activity.
In addition, a 5mg vial can support more concentration-range screening than microgram quantities in pre-portioned formats. For this reason, laboratories may choose the powder format for screening studies.
Key Research Areas
- Concentration-range screening from bulk powder
- Estrogen-related receptor agonist assays
- Orphan nuclear receptor pharmacology
- Mitochondrial biogenesis pathway research
- Working solution preparation from lyophilised material
Specifications
- Format: Lyophilised powder in a sealed research vial
- Size available: 5mg
- Pack options: 1 vial, 3 vials, or 10-vial pack
- Stated purity: 99%+
The Pre-Portioned Format and Related Material
For laboratories that prefer a fixed quantity, the same compound is also available as SLU-PP-332 capsules.
Another non-peptide research compound is Cardarine capsules. In addition, related mitochondrial research material includes MOTS-c.
Frequently Asked Questions
Why choose the vial over the capsules?
The powder allows a laboratory to set its own concentrations. Therefore, it can suit studies that screen SLU-PP-332 across a concentration range.
What size is the vial?
The vial contains 5mg of SLU-PP-332. You can order it individually or choose a 3-vial or 10-vial pack.
Research Use Only
SLU-PP-332 is supplied strictly for research use only. It is intended for qualified laboratory, analytical, or educational research applications.








